Sponsor pipeline

NanoPharmaceuticals LLC clinical trial pipeline

Get alerts when NanoPharmaceuticals LLC's trials change

1 active trials 0 recruiting 1 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-01
Primary completion pushed: 2026-10 → 2027-06
Enrollment closed, study ongoing
Completion pushed: 2027-10 → 2028-06
NCT05226494 Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma · Phase 1

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT05226494 Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma Glioma, Malignant Active, Not Recruiting 2026-08-31

Disease areas by active trials

Glioma (1)

Get alerts when NanoPharmaceuticals LLC's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free